Kayothera
PrivateLast Round
Grant
Jul 19, 2023
Total Funding Raised
$13.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kayothera is a biotechnology company that develops first-in-class, oral, small-molecule inhibitors of the retinoid nuclear receptor pathway for the treatment of cancer and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kayothera Comparables
Compare Kayothera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Io Therapeutics, Inc. | 82% | |
| Orphagen Pharmaceuticals | 82% | |
| Forkhead Biotherapeutics, Inc. | 73% | |
Kayothera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 19, 2023 | ||||
| Series A Extension | Jul 19, 2023 | ||||
| Series A | Mar 16, 2022 | ||||
| Seed | Aug 12, 2019 | ||||
| Seed | Mar 28, 2018 |
Key People
Founding team and executive leadership
Kayothera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series A, Series A Extension |
| Foundation Venture Capital Group | Seed |
| New Jersey Health Foundation | Seed |
| NIH RADx | Series A Extension, Grant |
| WRF Capital | Series A Extension |
| Washington Research Foundation Capital | Series A Extension |
| Pier 70 Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 108% MoM, reaching 1.7K.
- Jul 19, 2023
Received funding from Andy Hill Cancer Research Endowment Fund and NIH RADx.
Kayothera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kayothera's valuation, stock price, and market status.